Plato Investment Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.68K Hold
2,385
﹤0.01% 482
2025
Q4
$6.5K Hold
2,385
﹤0.01% 472
2025
Q3
$10K Hold
2,385
﹤0.01% 468
2025
Q2
$11.8K Buy
2,385
+13
+0.5% +$56 ﹤0.01% 470
2025
Q1
$10.6K Hold
2,372
﹤0.01% 488
2024
Q4
$11.1K Hold
2,372
﹤0.01% 546
2024
Q3
$16.4K Sell
2,372
-3,099
-57% -$24.3K ﹤0.01% 489
2024
Q2
$42.7K Buy
+5,471
New +$40.5K ﹤0.01% 405

Other funds holding GDRX

Plato Investment Management's GDRX Position: Q1 2026 in Review

Plato Investment Management held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 2,385 shares worth $4.68K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

Plato Investment Management first reported a position in GDRX in Q2 2024 and has held it in 8 quarters since. The position peaked at $42.7K in Q2 2024. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Plato Investment Management held 2,385 shares of GoodRx Holdings worth $4.68K as of Q1 2026.
  • Plato Investment Management left its GoodRx Holdings share count unchanged in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of Plato Investment Management's portfolio in Q1 2026, its #482 holding.
  • Plato Investment Management first reported a position in GoodRx Holdings in Q2 2024 and has held it in 8 quarters since.
  • Plato Investment Management's GoodRx Holdings position peaked at $42.7K in Q2 2024.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.